Philochem(瑞士)

Philochem

瑞士Philochemwww.philogen.comPhilogen成立于1996年,在瑞士与意大利的生物技术公司.Philogen的重点是生物制药的新血管生成有关的疾病的治疗发展。血管生成，即新血管的形成，是一个如癌症，类风湿关节炎，老年性黄斑变性的许多严重病症的特征。PhilogenisaSwiss-Italianintegratedbiotechnologycompanyfoundedin 1996bythebrothersDario,Duccio,GiovanniNeri,withtheinitialmissiontodevelopasproductsthepromisinghumanantibodiesdiscoveredbyProf.DarioNeri.Philogenfocusesonthedevelopmentofnewbiopharmaceuticalsforthetreatmentofangiogenesis-relateddisorders.Angiogenesis,i.e.theformationofnewbloodvessels,isacharacteristicfeatureofmanyseverepathologiessuchascancer,rheumatoidarthritisandage-relatedmaculardegeneration.Thecompanyhasbeenapioneerintheisolation,engineeringandclinicaldevelopmentofleadproductscapableoftargetingangiogenesisin-vivoandhasbeenthefirstintheworldtodemonstratethathumanmonoclonalantibodies,specificforamarkerofangiogenesis,canefficiently